Tagged Articles

oxycodone 21 articles

Nevada Cardiologist Pleads Guilty to Opioid Prescription Fraud

A Nevada cardiologist charged with widespread opioid and health care fraud pleaded guilty on Nov. 26 to one charge of illegal distribution of a controlled substance, federal authorities announced. Dr. Devendra Patel, 59, was the first physician in the state to face criminal drug distribution charges under a federal push to clamp down on opioid “pill mill” clinics and the doctors who run them. The government has stepped up efforts to beat back the rising tide of opioid addiction and death, which former U.S. Attorney General Jeff Sessions called the “worst drug crisis in American history.” Dr. Patel, who ran ... Read More

Florida Opioid Pill Mill Doctor, Staff Go to Prison

A South Florida doctor busted for illegally dispensing prescription opioid painkillers to cash-paying “patients” has been sentenced to six-and-a-half years in prison. Dr. Andres Mecia, 64, of Fort Lauderdale, ran an opioid pill mill in his Oakland Park, Florida clinic, Adult & Geriatric Institute of Florida Inc., which operated under the name AGI Medical & Dental. According to the government’s allegations, Dr. Mencia and office personnel — Oscar Luis Ventura-Rodriguez, 41, of Ft. Lauderdale; Nadira Sampath-Grant, 51, of Margate, and John Mensah, 50, of Miami, performed sham consultations with patients seeking opioid drugs. In these consultations, Dr. Mencia and his co-conspirators ... Read More

‘Death Diaries’ project reveals disturbing patterns in opioid prescribing

A doctor in San Diego, California, is working to fight the opioid epidemic by leading an effort to prevent future prescription drug overdose fatalities through the “San Diego Death Diaries,” a project that examines what drugs killed 254 people in 2013, and who prescribed them. Dr. Roneet Lev, head of emergency medicine at Scripps Mercy Hospital, set out to discover why there were so many unintended overdose deaths. She gathered information for 254 people who died of a drug overdose in 2013, and for each she created a diary entry that consists of the decedent’s name, age, and a list ... Read More

DEA raids LA pharmacy over ‘off the charts’ opioid prescriptions

Drug Enforcement Administration (DEA) officials raided a Chalmette, Louisiana, pharmacy about 10 miles east of New Orleans reportedly for dispensing opioids at a rate that was “off the charts,” making it one of the highest-prescribing pharmacies in the state, according to The Advocate. DEA authorities issued seizure warrants at Wilkinson Family Pharmacy and arrest warrants for the pharmacy’s owner Keith Wilkinson, and business partner. The agency worked in conjunction with the Sheriff’s office. The operation comes as neighboring New Orleans experienced a surge in accidental overdose deaths in 2016, for the first time surpassing murders in the parish. The problem ... Read More

DEA: Production of most opioids to be cut by one-quarter in 2017

The manufacturing of almost every schedule II opiate and opioid medication will be reduced by at least 25 percent in 2017, according to a Drug Enforcement Administration (DEA) Final Order published in the Federal Register. Some medications will be reduced even more, such as hydrocodone, which will be produced at 66 percent of last year’s level. The action is one more effort by the federal government to cut down on the growing problem of abuse of powerful opioid painkillers, which are the most abused and misused prescription medications on the market. The Aggregate Production Quota (APQ) system was put in place ... Read More

FDA approves powerful OxyContin for pediatric patients

The Food and Drug Administration (FDA) has just approved that children as young as 11 with certain medical conditions can be prescribed the powerful and addictive opioid painkiller OxyContin. Purdue Pharma, makers of OxyContin, tested the drug in children ages 11 to 16 who needed prolonged opioid treatment such as after a significant trauma or following major surgeries including those of the spine or to correct certain birth defects. The research also helped identify proper dosing for pediatric patients. The FDA granted the new indication for the drug based on this information, said Dr. Sharon Hertz, director of new anesthesia, ... Read More

FDA approves oxycodone combination drug that resists abuse

A powerful combination opioid painkiller whose euphoric effects can be rendered inactive if the drug is tampered with has been approved by the Food and Drug Administration (FDA). The drug’s formulation aligns with the agency’s commitment to combat the misuse and abuse of opioids. “The development of opioids that are harder to abuse is needed in order to help address the public health crisis of prescription drug abuse in the U.S.,” Dr. Sharon Hertz, deputy director of the division of anesthesia, analgesia, and addiction products in the FDA’s Center for Drug Evaluation and Research, said in an news release. Targiniq ... Read More

FDA revokes approval for seven painkillers containing acetaminophen

The U.S. Food and Drug Administration (FDA) has revoked approval for seven narcotic painkillers containing acetaminophen, including versions of AbbVie Inc.’s Vicodin. The agency has done this in response to recent concerns about these drugs’ potential of causing liver damage. Just three years earlier, regulators announced a plan to cap the amount of acetaminophen allowed per dose to 325 milligrams. Three versions of Abbvie’s Vicodin that combine acetaminophen and hydrocodone were affected by this. Also, companies such as Actavis Inc., Nesher Pharmaceuticals USA LLC, West-Ward Pharmaceutical Corp, and Leitner Pharmaceuticals LLC, that all made products containing acetaminophen had those product ... Read More

FDA panel rejects new opioid painkiller combining morphine, oxycodone

A Food and Drug Administration (FDA) advisory panel has voted unanimously not to recommend the approval of a powerful new prescription painkiller designed to deliver faster relief with fewer side effects. Moxduo is the first drug to combine morphine and oxycodone in one capsule. It is intended to treat moderate to severe pain, such as that associated with accidents and major surgery. Panel members said the drug’s developer QRxPharma did not adequately prove that Moxduo provides better pain relief than morphine or oxycodone alone, nor that the drug is less likely to cause potentially fatal respiratory depression compared to its ... Read More

Legislation aims to revoke FDA’s approval of new opioid Zohydro

A group of lawmakers concerned about health risks and a growing epidemic of prescription drug abuse has introduced legislation to revoke the Food and Drug Administration’s approval of the new, highly potent opioid painkiller Zohydro ER. “I have tried reasoning with the FDA, and I’ve repeatedly requested the agency change its course on this dangerous drug. Their refusal to budge forces me to introduce legislation,” Sen. Joe Manchin, D-W.Va., said in a statement. He teamed up with Rep. Stephen Lynch D-Mass, and Rep. Hal Rogers, R-Ky., on the bill. Zohydro ER is the first pure hydrocodone drug to be approved ... Read More